REHOVOT, ISRAEL — Aleph Farms, a cultivated meat company that grows steaks from non-genetically engineered animal cells, announced Yifat Gavriel as the new chief of regulatory affairs and quality assurance. Gavriel will help with commercialization, specifically bringing the company’s products to global markets.

“Yifat brings valuable expertise to the team, and we are delighted to have her join us at such a critical juncture in our journey to market,” said Didier Toubia, chief executive officer and co-founder of Aleph Farms. “In our work with regulatory agencies around the world, we have seen firsthand how they encourage innovation and have been willing to continue transparent dialogues with us and the wider cultivated meat industry. The next six to 12 months will prove critical as we work closely with regulators to launch our first product in key markets.”

Gavriel has over 15 years of experience in quality assurance and regulatory affairs management. She has assured product quality compliance in 10 different manufacturing sites around the world, marketing products in more than 20 regions. Most recently, Gavriel served as head of regulatory affairs at Omrix Biosurgery Israel, a subsidiary of Johnson & Johnson.

“Joining Aleph Farms presents an exciting opportunity and challenge at this stage of my career, and I am looking forward to working together with Didier and the rest of the team to ensure that our quality management complies with the highest international standards,” Gavriel said. “Cultivated meat is a great complement to sustainably farmed animal products and alternative proteins. Now it’s a matter of making sure the different regulatory needs are met to bring our products to consumers around the world in a timely manner.”

Aleph Farms said the regulatory approval process for cultivated meat is underway in many countries, with Singapore Food Agency as the first to approve it as an ingredient in 2020. The first product Aleph Farms plans to introduce to markets is a thin-cut cultivated beef steak.